E1208 A Phase III Randomized, Double-Blind Trial of Chemoembolization
E1208 A Phase III Randomized, Double-Blind Trial of Chemoembolization with or without Sorafenib in Unresectable Hepatocellular Carcinoma (HCC) in Patients with and without Vascular Invasion | |
|---|---|
| Sponsor(s) | Frontier Science and Technology Research Foundation |
| Principal Investigator(s) | John Kauh, MD |
| Dates | 3/16/2010 - 3/16/2014 |
